retatrutide phase 3 2025 triple agonist glp-1 gip glucagon A review of an investigational drug retatrutide, a novel agent for the treatment of obesity | European Journal of Clinical Pharmacology Retatrutide (Eli Lilly's triple GLP-1/GIP/Glucagon

Don't leave the vial sitting open or the needle inserted for longer than necessary

First, it enhances nitric oxide production, which relaxes blood vessels and improves local circulation

How Do GLP-1 Injections Work

Setting accurate expectations is the difference between a patient who follows through and one who abandons a protocol at week 4 because they expected results at week 2

your complete care Your personalized GLP-1 Longevity care starts with membership personalized GLP-1 Longevity care starts with membership Patient voices I speak with the Healthspan team monthly about my protocols and their effects on my bloodwork (which I do quarterly)

Finally, we found that tirzepatide consistently increased somatostatin secretion (Fig